Loading…
Poison Control Centers Reauthorization Act of 2024
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
83pct
101d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Health Issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers. S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024 H.R.7251, the Poison Control Centers Reauthorization Act of 2024 H.R.7213, Autism CARES Act Reauthorization Issues related to solid organ transplantation and OPTN reforms. Issues related to regulation of laboratory developed tests. Issues related to the expansion of telehealth services. Issues related to electronic prescribing. Issues related to the proposed IOTA transplant reimbursement model.
Placed on the Union Calendar, Calendar No. 425.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-512.
Congress.gov source codes: 5000, H12200
Ordered to be Reported (Amended) by the Yeas and Nays: 47 - 0.
Committee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 23 - 0.
Subcommittee Consideration and Mark-up Session Held
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers. S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024 H.R.7251, the Poison Control Centers Reauthorization Act of 2024 H.R.7213, Autism CARES Act Reauthorization Issues related to solid organ transplantation and OPTN reforms. Issues related to regulation of laboratory developed tests. Issues related to the expansion of telehealth services. Issues related to electronic prescribing. Issues related to the proposed IOTA transplant reimbursement model.
Client expense: $30,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
Federal funding for emergency medicine research activities H.R. 7251-To amend the Public Health Service Act to reauthorize certain poison control programs S. 4351-To amend the Public Health Service Act to reauthorize certain poison control programs
Client expense: $407,855 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers. H.R.5378, Lower Costs, More Transparency Act, issues related to reimbursement cuts and administrative burdens on hospitals. S.765/H.R.1526, the Reducing Hereditary Cancers Act. H.R.4286, the Increasing Access to Lung Cancer Screening Act. H.R.1711/S.940, the Rural America Health Corps Act. S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024 H.R.7251, the Poison Control Centers Reauthorization Act of 2024 H.R.7213, Autism CARES Act Reauthorization Issues related to solid organ transplantation and OPTN reforms. Issues related to regulation of laboratory developed tests. Issues related to the expansion of telehealth services. Issues related to electronic prescribing. Issues related to the proposed IOTA transplant reimbursement model.
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Federal funding for emergency medicine research activities H.R. 7251-To amend the Public Health Service Act to reauthorize certain poison control programs S. 4351-To amend the Public Health Service Act to reauthorize certain poison control programs
Client expense: $428,634 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers. H.R.5378, Lower Costs, More Transparency Act, issues related to reimbursement cuts and administrative burdens on hospitals. S.765/H.R.1526, the Reducing Hereditary Cancers Act. H.R.4286, the Increasing Access to Lung Cancer Screening Act. H.R.1711/S.940, the Rural America Health Corps Act. S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024 H.R.7251, the Poison Control Centers Reauthorization Act of 2024 Issues related to solid organ transplantation and OPTN reforms. Issues related to regulation of laboratory developed tests. Issues related to the expansion of telehealth services. Issues related to the Mission Zero Act grant program for civil-military trauma training partnerships. Issues related to intellectual and developmental disability research, professional training and services.
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
Federal funding for emergency medicine research activities H.R. 7251-To amend the Public Health Service Act to reauthorize certain poison control programs S. 4351-To amend the Public Health Service Act to reauthorize certain poison control programs
Client expense: $509,774 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
S.2768/H.R.2584, the SAVE Act, issues related to violence against health care providers. H.R.5378, Lower Costs, More Transparency Act, issues related to reimbursement cuts and administrative burdens on hospitals. S.765/H.R.1526, the Reducing Hereditary Cancers Act. H.R.4286, the Increasing Access to Lung Cancer Screening Act. H.R.1711/S.940, the Rural America Health Corps Act. S.3765/H.R.6960, the Emergency Medical Services for Children Reauthorization Act of 2024 H.R.7251, the Poison Control Centers Reauthorization Act of 2024 Issues related to information blocking rule. Issues related to solid organ transplantation and OPTN reforms. Issues related to regulation of laboratory developed tests. Issues related to the expansion of telehealth services.
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
| Republican |
| GA |
| John Joyce | Republican | PA |
| Paul Tonko | Democratic | NY |
| Sheila Cherfilus-McCormick | Democratic | FL |